Patients with non-alcoholic steatohepatitis (NASH) have also been characterized by low hepatic HNF4A expression, in line with the dramatically decreased HNF4A levels observed in livers from mice with genetic or diet-induced obesity [145]. This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatohepatitis.